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Candida parapsilosis has become a significant cause of invasive fungal infections in seriously ill patients. Nosocomial outbreaks
through direct and indirect contact have been described. The aim of this study was the molecular characterization of what ap-
peared to be an ongoing C. parapsilosis outbreak at the cardiothoracic intensive care unit of the University Hospital of Vienna
between January 2007 and December 2008. Using two different molecular typing methods—automated repetitive sequence-
based PCR (DiversiLab; bioMérieux) and microsatellite genotyping—we investigated the genetic relationship of 99 C. parapsilo-
sis isolates. Eighty-three isolates originated from the cardiothoracic intensive care unit, while 16 isolates were random control
isolates from other intensive care units and a different Austrian hospital. The 99 C. parapsilosis isolates analyzed by repetitive-
element PCR all showed identical genotypes, suggesting an ongoing outbreak. In contrast, microsatellite genotyping showed a
total of 56 different genotypes. Twomajor genotypes were observed in 10 and 15 isolates, respectively, whereas another 13 geno-
types were observed in 2 to 4 isolates each. Forty-one genotypes were observed only once. Closely related genotypes that differed
in only a single microsatellite marker were grouped into clonal complexes. When it comes to C. parapsilosis, microsatellite geno-
typing is a more discriminative method than repetitive-element PCR genotyping to investigate outbreaks.
Invasive fungal infections are severe and life-threatening compli-cations in immunocompromised or seriously ill patients. Can-
dida species are the cause of nosocomial sepsis, septic shock, and
lethal disseminated infection in critically ill patients admitted to
intensive care units (ICUs), rising over the past decade to the
fourth most common pathogens causing nosocomial blood-
stream infections in the United States (3). The increasing fre-
quency rate of serious Candida hospital infections in intensive
care patients has multifactorial causes, including increasing usage
of intravascular catheters, broad-spectrum antibiotics, extensive
surgery, and immunosuppression for neoplastic disease or allo-
graft preservation (2, 8). Despite the availability of potent antifun-
gal agents, the mortality rate from invasiveCandida infection is up
to 65% (16).
With Candida albicans being still the most common pathogen
isolated from immunosuppressed patients, the incidence of isola-
tion of so-called non-albicans Candida, C. glabrata or C. parapsi-
losis, has been increasing in Europe (1, 19, 20). Candida parapsi-
losis strains, though, are more heterogeneous than other Candida
species. Tavanti and colleagues suggested a division of the C.
parapsilosis group (sensu lato) into three species named C. parap-
silosis sensu stricto (or simply Candida parapsilosis), C. orthopsi-
losis, andC.metapsilosis (18). Although frequently associated with
neonates and the use of parenteral nutrition, the epidemiology of
C. parapsilosis is more complex, as demonstrated in a recent mul-
ticenter study by Cantón and coworkers. They found C. parapsi-
losis most frequently in adult intensive care unit, surgery, and
internal medicine departments, and in their study, mostC. parap-
silosis candidemias were observed in adults (4). Moreover, the new
class of echinocandin broad-spectrum antifungals—although
very active against C. albicans or C. glabrata—shows increased
MICs against most clinical isolates of the C. parapsilosis group
(15), with differences at the species level (3).
Candida parapsilosis nosocomial outbreaks have been reported
to occur not only through direct and indirect contact via the hands
of health care workers but also through contaminated patient care
equipment (5, 12, 13, 21). The close genetic relatedness of C.
parapsilosis strains in clinical settings emphasizes the need for re-
liable identification methods to clarify potential transmission
routes. As current methods for yeast identification are based on
phenotypic features, they can neither differentiate among the
three closely related C. parapsilosis sensu lato species nor reliably
discriminate isolates below the species level within the C. parapsi-
losis sensu stricto group. To ensure optimal therapeutic options
and study nosocomial cross-transmission, molecular identifica-
tion ofC. parapsilosis outbreak isolates at the species level is there-
fore of utmost importance (10).
During a 2-year observation period, a conspicuous coloniza-
tion with C. parapsilosis was observed at one adult cardiothoracic
intensive care unit at the University Hospital of Vienna. Genotyp-
ing with conventional methods indicated a pseudo-outbreak in-
volving 50 patients with 83 colonizing isolates. Here we report the
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use of additional microsatellite genotyping ofC. parapsilosis using
a six-marker microsatellite panel.
MATERIALS AND METHODS
Study setting. Our study population was derived from a larger prospec-
tive study (unpublished data) conducted at the University Hospital of
Vienna—a 2,200-bed tertiary care medical university teaching hospital—
between December 2006 and December 2008. During a 2-year period, all
nonneutropenic cardiac surgery patients admitted to the ICU longer than
7 days were consecutively enrolled into the prospective study. To detect
Candida colonization, surveillance culture samples were taken twice
weekly from different superficial sites, open wounds, and anus and ana-
lyzed for the presence of Candida using routine methods for culture and
identification. Over the 24-month period, a total of 199 patients were
enrolled. Of 199 patients, 148 were colonized with Candida spp. at any
site. Candida albicans was the predominant colonizing species, recovered
from 142 patients, followed byC. parapsilosis, recovered from 50 patients.
Molecular characterization followed for all colonizing isolates from that
prospective study found to be C. parapsilosis. The study was approved by
the Ethics Review Committee of the Medical University of Vienna (EC no.
510/2006).
Samples. A total of 99 colonizing isolates were investigated using two
different molecular typing methods. Eighty-three colonizing isolates from
urine samples (n 6) and from superficial sites, including anus (n 4),
axilla (n 10), groin (n 29), nose (n 17), respiratory tract (n 14),
wound (n 1), and other (n 2), of 50 patients were collected during the
period of the above-mentioned prospective study. Nine samples from
patients of other intensive care units at our hospital as well as seven iso-
lates from another Austrian hospital were also included in our analysis
and used for comparison purposes.
Culture and identification. All isolates were grown for 48 h on Sab-
ouraud glucose agar medium (Heipha Diagnostika, Eppelheim, Ger-
many) at 37°C. Identification was done using the API ID 32C (bioMérieux
Austria GmbH) according to the manufacturer’s instructions.
DNA extraction. DNA from each of the 99 colonizing isolates was
extracted using the UltraClean microbial DNA isolation kit (Mo Bio Lab-
oratories) by following the manufacturer’s instructions. We used 5
U/l of the enzyme Zymolyase (Zymo Research Corporation, Irvine,
CA). The DNA concentration was adjusted to approximately 25 ng/l
for each sample.
Molecular characterization by automated rep-PCR typing system
(DiversiLab). All DNA samples obtained from the 99 colonizing isolates
were amplified using the DiversiLab Candida kit for DNA fingerprinting
(bioMérieux Austria GmbH) by following the manufacturer’s instruc-
tions. Briefly, 25 ng genomic DNA, 2.5 U AmpliTaq polymerase, 2.5 l
10 PCR buffer (Applied Biosystems, CA), and 2 l primer mix were
added to the repetitive sequence-based PCR (rep-PCR) master mix in a
total volume of 25 l per reaction. Thermal cycling parameters were as
follows: initial denaturation of 94°C for 2 min, followed by 35 cycles of
denaturation at 92°C for 30 s, annealing at 50°C for 30 s, and extension at
70°C for 90 s, with a final extension at 70°C for 3 min. Detection of
rep-PCR products was done by microfluidic chips and a model B2100
bioanalyzer (Agilent Technologies, Inc., Palo Alto, CA) of the DiversiLab
system, and analysis was performed with DiversiLab software, version 3.4.
The resulting DNA fingerprint patterns were viewed as electrophero-
grams, and the results included a dendrogram with a similarity matrix and
a virtual gel image of the fingerprint for each DNA sample (11).
Microsatellite typing.A panel of six short tandem repeat (STR) mark-
ers was used for genotyping theC. parapsilosis isolates. Three trinucleotide
repeat markers as described earlier by Sabino et al. (17) were amplified in
a multiplex PCR. For these markers, we redesigned the amplification
markers to generate shorter PCR products and to amplify all three in one
multiplex PCR. Instead of the dinucleotide marker described before, we
added a panel of three hexanucleotide markers. In each panel, one of the
amplification primers (Table 1) was labeled with either 6-carboxyfluores-
cein (FAM), hexachlorofluorescein (HEX), or 6-carboxytetramethylrho-
damine (TAMRA). Amplification reactions were performed in a final vol-
ume of 25 l containing approximately 1 ng genomic DNA, 0.5 M
amplification primers, 0.2 mM deoxynucleoside triphosphates (dNTPs),
3 mM MgCl2, and 1 U FastStart Taq DNA polymerase (Roche Diagnos-
tics, Almere, the Netherlands) in 1 reaction buffer (Roche Diagnostics).
Thermocycling was performed in a T1 thermocycler (Biometra, Göttin-
gen, Germany) using the following conditions: initial denaturation for 10
min at 95°C, followed by 35 cycles of 30 s of denaturation at 95°C, 30 s of
annealing at 60°C, and 1 min of extension at 72°C. A final incubation of 10
min at 72°C was included before the reactions were cooled to room tem-
perature. Following PCR, the amplification products were diluted 30-fold
with distilled water and a 1-l aliquot of diluted PCR product was added
to 8.75 l distilled water and 0.25 l internal size marker ET-ROX 400
(GE Healthcare, Diegem, Belgium). After denaturation of the samples at
95°C for 1 min and rapid cooling to 4°C, they were injected and run onto
a MegaBACE 500 platform (GE Healthcare) equipped with a 48-capillary
array as recommended by the manufacturer. The number of repeats in
each marker was determined by comparing the relative size of each allele
to those obtained using the reference C. parapsilosis strain CDC317,
whose genome has been fully sequenced. Diploid genotypes were con-
verted to binary data by scoring the presence (“1”) or absence (“0”) of
each possible allele. Similarities between genotypes were visualized by
constructing a minimum spanning tree using BioNumerics, version 6.0
(Applied Maths, St.-Martens-Latem, Belgium), treating the data as cate-
gorical information.
RESULTS
By using two different molecular typing methods—automated re-
petitive sequence-based PCR (rep-PCR) (DiversiLab) and micro-
satellite-based genotyping—we investigated the genetic relation-
ship of 99 Candida parapsilosis isolates from 56 different patients.
Eighty-three colonizing isolates from 50 patients were issued from
that prospective study, while nine samples from other ICUs and
seven samples from another Austrian hospital were included for
comparison purposes.
Genotyping of the 99 C. parapsilosis isolates using repetitive-
element PCR showed identical rep-PCR genotype patterns (data
not shown) irrespective of the patient’s identity, the patient’s lo-
cation, and the time of sampling. In contrast, microsatellite geno-
TABLE 1 Overview of amplification primers used in this study







a The underlined G nucleotide in the unlabeled primer sequence is not a match to the genomic DNA but was introduced to minimize the formation of minus-A peaks (7).
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typing using a panel of six STR markers identified 56 different
genotypes, of which 41 were observed only once. Fifteen geno-
types were found multiple times and were numbered I to XV. The
two most prevalent genotypes (I and II) were found in 10 and 15
isolates and were retrieved from three and eight patients, respec-
tively. Seven genotypes (III to IX) each contained two to four
isolates from different patients (Table 2), while the remaining six
genotypes (X to XV) involved only one patient each, with two
isolates from different anatomic sites taken from this patient over
time. A timeline of the nine genotypes involving more than one
patient is given in Fig. 1. While with genotypes I, II, and IV there
was an overlap in the times of stay of some of the patients, this was
not the case for genotypes III, V to VIII, and IX (Fig. 1). The
relationship between the obtained genotypes is illustrated in Fig.
2. From the minimum spanning tree it is clear that some geno-
types may have evolved by spontaneous changes in one of the
microsatellite markers. This can be recognized from the com-
plexes of apparently closely related genotypes that differed in only
one of the six microsatellite markers (indicated as A to F in
Fig. 2A). Six of such complexes containing a total of 53 isolates
were recognized. From 18 patients, multiple isolates were avail-
able. In nine patients, this involved only a single genotype,
whereas in two patients, two different but closely related geno-
types were found. In the remaining seven patients, two or more
clearly different genotypes were found over time. In one patient,
different genotypes were recovered on the same day but from dif-
ferent body sites.
To illustrate the discriminatory power of the microsatellite
panel, we compared the genotypes to those found from different
wards and from a different hospital. All nine control isolates from
different wards yielded different genotypes. Only one of these ge-
notypes was also found in our study population, and another iso-
late was of a different but related genotype. None of the seven
isolates from a different hospital were found in our study collec-
tion (Fig. 2B).
DISCUSSION
Different molecular typing methods, such as random amplified
polymorphic DNA typing, restriction fragment length polymor-
phism, and multilocus sequence typing to classify C. parapsilosis
sensu lato into three distinct species according to Tavanti and
TABLE 2 Candida parapsilosis strain typing results using microsatellite
genotyping: relationship between genotypes I to IX and clonal
complexes of genotypes for 28 patients harboring genotypes I to IX at
the cardiothoracic intensive care unit of the University Hospital of










I 10 (3) 262799106404410128877 A
II 15 (8) 26265151404010108877 B
III 4 (3) 26275050474710108877 NR
IV 3 (2) 26264545404110108877 NR
V 3 (2) 26273636404619198877 NR
VI 3 (3) 25273636374314148877 C
VII 2 (2) 262799106444410128877 A
VIII 3 (3) 15155959434414148877 D
IX 2 (2) 2627106106404410128877 A
a A to D indicate clonal complexes of genotypes differing in only one microsatellite
marker. NR, not part of a clonal complex.
FIG 1 Timeline showing length of stay and potential overlap of stay for 28 patients harboring genotypes I to IX at the cardiothoracic intensive care unit of the
University Hospital of Vienna during the 24-month study period. The relationship between genotypes I to IX and clonal complexes of genotypes is also shown.
* C.C., clonal complex of genotypes where A to D indicate clonal complexes of genotypes differing in only one of the six microsatellite markers. n.r., there is no
relationship to a clonal complex. Numbers with a superscript “1” and a superscript “2” are dates of admission to and discharge from the cardiothoracic intensive
care unit, respectively. Admission or discharge dates are given only if there is an overlap of stay of patients with the same genotype.
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coworkers, have been described previously (18, 22). In 2006,
Lasker and colleagues reported a microsatellite method based on
dinucleotide repeats able to distinguish isolates within the C.
parapsilosis sensu stricto group (14). More recently, Sabino and
coworkers also described a new DNA typing method with even
higher discriminatory power involving microsatellite loci able to
distinguish among C. parapsilosis sensu stricto isolates (17).
Surveillance culture samples were taken twice weekly from dif-
ferent superficial sites of all patients hospitalized on the cardio-
thoracic intensive care unit of the Vienna University Hospital be-
tween December 2006 and December 2008. Eighty-three isolates
from 50 patients all from this cardiothoracic intensive care unit
were found to beC. parapsilosis. Repetitive-element PCR genotyp-
ing results suggested that we were facing an ongoing outbreak of
C. parapsilosis in this ICU. For comparison purposes, nine addi-
tional isolates were obtained from other ICUs at our hospital, and
seven isolates were obtained from another Austrian hospital. All
additional nonoutbreak isolates analyzed by automated repeti-
tive-sequence-based PCR typing system did as well show the iden-
tical rep-PCR genotype. In order to clarify this potential outbreak,
the isolates were then further analyzed by microsatellite genotyp-
ing. Microsatellite genotyping identified all 16 nonoutbreak iso-
lates as being 16 clearly different genotypes. Within the 83 out-
break isolates, 26 genotypes were observed only once. The
remaining 15 genotypes each represented a separate cluster. Our
findings suggest that for 82% (41/50) of our patients, C. parapsi-
losis isolates were already present as part of the colonizing flora of
the patients and were selected in the intensive care setting, where
antimicrobial and antifungal treatment is widely administered.
Because of the intrinsic instability of the microsatellite loci, iso-
lates with only very minor changes in one of the microsatellite
markers are being considered to be clonally related though not
identical, as was the case for four of our patients. The isolation of
patient-specific or clonally related genotypes of C. parapsilosis
from multiple anatomical sites over time in 24% (12/50) of our
patients further supports the evidence of an endogenous coloni-
zation with those Candida isolates (23). Nevertheless, nosocomial
transmission cannot be excluded with isolates of genotypes I, II,
and IV, since there was an overlap in the times of stay of some of
the patients, as well as for those seven patients for whom two or
three clearly distinct genotypes were found. Prevention strategies
aimed at C. parapsilosis must therefore take into account appro-
priate control measures against both exogenous and endogenous
infection reservoirs.
In our daily infection control, routine DNA typing methods
have proven to be very valuable in studying the genetic relatedness
among microorganisms involved in possible outbreak settings.
DiversiLab typing is a rapid and easy-to-perform method for ini-
tial screening during outbreak investigation for different bacterial
species, as described by Fluit and colleagues for Acinetobater spp.,
Stenotrophomonas maltophilia, and the Enterobacter cloacae com-
FIG 2 Minimum spanning tree showing the differences between the geno-
types based on a categorical analysis. Each circle represents a unique genotype.
The size of the circle corresponds to the number of isolates of that genotype.
Numbers correspond to the number of differences between the genotypes. (A)
Clonal complexes of genotypes differing in only one microsatellite marker are
indicated with colors and lettered A to F. (B) Origin of the samples: green,
study collection; yellow, isolates from different wards; red, isolates from an-
other hospital.
Microsatellite Genotyping of a Candida parapsilosis Outbreak













plex (9) and as recently described by Deplano and coworkers for
Enterococcus faecium and Klebsiella pneumoniae (6). Regarding
Candida species, Wise and colleagues did show that DiversiLab
was able to discriminate between the medically important mem-
bers of the genusCandida at the species level (24). However, when
it comes to C. parapsilosis strain differentiation, our study could
demonstrate that DiversiLab typing has limited discriminatory
power and therefore needs to be replaced by a more discriminative
method such as microsatellite genotyping to investigate outbreaks
where C. parapsilosis is involved.
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